Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Study Reveals Scope, Characteristics of Adverse Drug Reactions in General Population

By Wiley | October 19, 2016

In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.

The most common ADRs were gastrointestinal-related, while the most common drug category causing ADRs were cardiovascular drugs.

Patients with ADRs had a longer length of stay in the hospital than those who did not (median 4 versus 3 days). Some of the ADRs may have been partially predictable based on patients’ genetics.

“This study is important because we have quantified the burden of clinically impactful ADRs in the general adult population in Singapore for the very first time. Furthermore, results of this study provide essential directions to future pharmacogenomic research for reduction of ADR-related hospitalizations in Singapore,” said Professor Alexandre Chan, co-senior author of theBritish Journal of Clinical Pharmacology study.

Studies based on medical records review in the UK and other countries have reported that the prevalence of hospital admissions caused by ADRs range from 2.3 percent to 21.2 percent, and that a substantial proportion of these ADRs are potentially preventable.

Related Articles Read More >

RCSB Protein Data Bank now has more than 1,000 SARS-CoV-2 proteins
Data sciencea
Q&A: Keys to unlock data science potential for drug discovery
Ivermectin not supported for mild COVID-19, study says
Emulate Bio
Organ-chips could streamline drug development, but hurdles remain

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards